New therapeutic target against persistent viral infections

January 11, 2017

Life is a question of balance, and the body is no exception. Expression levels of certain proteins can affect the immune system's ability to neutralize a virus. Type I interferons (IFN-I) are cytokines that were previously thought of as key contributors to the antiviral response, but emerging lines of evidence suggest that they may also participate in the establishment and maintenance of persistent viral infections.

Professor Alain Lamarre and his team at the INRS-Institut Armand-Frappier Research Centre have made significant advances in our understanding of the role of IFN-I in this setting. Their findings could lead to the development of novel therapeutic approaches against such as those caused by the hepatitis C (HCV) or the (HIV).

Multiple type I interferon signalling pathways

IFN-I is synthesized by a large number of and triggers diverse responses in target cells using various signalling pathways. During a typical virus infection, the virus replicates in the infected cell and induces IFN-I expression through pattern recognition receptors (PRRs) signalling. The cytokine then binds a specific receptor (IFNAR) to adjacent cells, which usually triggers reactions that stimulate the host's immune defences. However, the effect on chronic infections is different because prolonged exposure to IFN-I has negative immunomodulatory effects.

The role of IFN-I in chronic viral infections

Persistent viral infections, particularly those caused by HCV, HIV, and lymphocytic choriomeningitis virus (LCMV), an experimental model of lead to a number of dysfunction to the humoral such as an excessive production of non-specific antibodies (hypergammaglobulinemia) and a dysregulation of B cell subpopulations.

The most recent work by professor Lamarre's team has focused on the molecular mechanisms that disrupt the immune system during . The study's results highlight numerous mechanisms that explain the role of IFN-I in immune response disruptions. Using specific markers, professor Lamarre's team observed an abnormal increase in the expansion of TFH (a subpopulation of CD4+ T cells), which in this case triggers the expansion of non-specific B lymphocytes. The increased amount of TFH also reduces the proportion of other T cells that help fight infection.

The team has also demonstrated that IFN-I signalling affects the humoral response more directly. They have successfully restored antigen-specific responses by blocking B cell IFN-I receptors. Therefore, IFN-I acts directly on B cells to increase non-specific responses while impairing antigen-specific responses.

Professor Lamarre's team has identified the signalling pathways involved in disrupting the humoral immune response during the chronic phase of LCMV infection, but the complex responses caused by IFN-I require further characterization. While it is unclear if sustained IFN-I production is a cause or consequence of persistent viral infection, it clearly plays an important role in humoral response disruption offering a promising therapeutic target against chronic viral infections.

Explore further: Inflammation triggers unsustainable immune response to chronic viral infection

More information: Matthieu Daugan et al. Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection, Frontiers in Immunology (2016). DOI: 10.3389/fimmu.2016.00564

Armstrong Murira et al. Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection, Frontiers in Immunology (2016). DOI: 10.3389/fimmu.2016.00609

Related Stories

Inflammation triggers unsustainable immune response to chronic viral infection

October 21, 2016
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have ...

Understanding immune reaction to the hepatitis B virus

November 28, 2016
A collaboration of researchers from Japan and Malaysia has further clarified the immune response to hepatitis B virus through in vivo experimentation.

Zika virus infection alters human and viral RNA

October 20, 2016
Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications—chemical tags known as ...

Immune 'traffic jam' from viral infection interferes with therapeutic antibodies

February 12, 2015
Several drugs now used to treat cancer and autoimmune diseases are actually repurposed tools derived from the immune system. One of the ways these "therapeutic antibodies" work is to grab onto malignant or inflammatory cells ...

Vaccine-induced CD4 T cells have adverse effect in a mouse model of infection

January 15, 2015
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has found that a vaccine that elicits only CD4 T cells against a mouse model of a chronic viral infection results in an overwhelming—and lethal—inflammatory ...

Scientists identify interferon beta as likely culprit in persistent viral infections

May 13, 2015
Interferon proteins are normally considered virus-fighters, but scientists at The Scripps Research Institute (TSRI) have found evidence that one of them, interferon beta (IFNβ), has an immune-suppressing effect that can ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.